Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Stereotactic Radiosurgery in the Management of Brain Metastases: A Case-Based Radiosurgery Society Practice Guideline. Advances in radiation oncology Ladbury, C., Pennock, M., Yilmaz, T., Ankrah, N. K., Andraos, T., Gogineni, E., Kim, G. G., Gibbs, I., Shih, H. A., Hattangadi-Gluth, J., Chao, S. T., Pannullo, S. C., Slotman, B., Redmond, K. J., Lo, S. S., Schulder, M. 2024; 9 (3): 101402

Abstract

Brain metastases are common among adult patients with solid malignancies and are increasingly being treated with stereotactic radiosurgery (SRS). As more patients with brain metastases are becoming eligible for SRS, there is a need for practical review of patient selection and treatment considerations.Two patient cases were identified to use as the foundation for a discussion of a wide and representative range of management principles: (A) SRS alone for 5 to 15 lesions and (B) a large single metastasis to be treated with pre- or postoperative SRS. Patient selection, fractionation, prescription dose, treatment technique, and dose constraints are discussed. Literature relevant to these cases is summarized to provide a framework for treatment of similar patients.Treatment of brain metastases with SRS requires many considerations including optimal patient selection, fractionation selection, and plan optimization.Case-based practice guidelines developed by the Radiosurgery Society provide a practical guide to the common scenarios noted above affecting patients with metastatic brain tumors.

View details for DOI 10.1016/j.adro.2023.101402

View details for PubMedID 38292892

View details for PubMedCentralID PMC10823095